These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 18418595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan.
    Chauvelot P, Skanjeti A, Jamilloux Y, de Parisot A, Broussolle C, Denis P, Ramackers JM, Giammarile F, Kodjikian L, Seve P.
    Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
    [Abstract] [Full Text] [Related]

  • 10. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
    Yokoyama R, Miyagawa M, Okayama H, Inoue T, Miki H, Ogimoto A, Higaki J, Mochizuki T.
    Int J Cardiol; 2015 Sep 15; 195():180-7. PubMed ID: 26043154
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The impact of 18F-FDG PET/CT in patients with liver metastases.
    Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji JB, Ell PJ.
    Eur J Nucl Med Mol Imaging; 2007 Dec 15; 34(12):1906-14. PubMed ID: 17713766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L.
    Acad Radiol; 2014 May 15; 21(5):675-84. PubMed ID: 24703482
    [Abstract] [Full Text] [Related]

  • 15. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS.
    J Nucl Cardiol; 2020 Dec 15; 27(6):2118-2129. PubMed ID: 30603887
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic yield of whole-body 18F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
    Saleh JK, Barkmeier D, Frey KA, Davenport MS.
    J Nucl Cardiol; 2023 Oct 15; 30(5):1773-1781. PubMed ID: 36829085
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M.
    J Card Fail; 2015 Apr 15; 21(4):313-22. PubMed ID: 25512195
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.